English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Celgene Corporation
Karen Kidd
| Oct 23, 2018
Think tank founder recommends standard patents over intellectual property rights to cut drug prices
Carrice Quinnie
| Jun 2, 2017
Celgene sees positive results in trial of oral ozanimod for relapsing multiple sclerosis
LocalLabs News Service
| Apr 10, 2017
Oral medication reduced psoriasis symptoms, study says
Gene Johnson
| Mar 10, 2017
FDA accepts Celgene Corp.'s application for leukemia treatment drug
Amanda Rupp
| Aug 19, 2016
Torres, Celgene partner for psoriasis campaign
Amanda Rupp
| Jun 1, 2016
World MS Day research to increase independence of MS patients
Amanda Rupp
| May 16, 2016
Acute myeloid leukemia persists as major health problem
Amanda Rupp
| Apr 14, 2016
WHO calls for better accessibility to psoriasis treatments
Trending
+
Community
Patient Daily
| Apr 17, 2025
ENT Practice Expert: OTO Forum 2025 will feature 'at least four topics that stand out as vital for doctors'
+
Pharmaceuticals
Patient Daily
| Apr 17, 2025
UCSF neurosurgeon: 'The idea that 340B is about helping the poor is a fiction'
+
Pharmaceuticals
Patient Daily
| Apr 22, 2025
National Consumers League CEO: 340B program abuse is 'a financial bonanza for non-profit hospitals'
+
Pharmaceuticals
Patient Daily
| Apr 23, 2025
State Sen. Baldacci: 340B reform ‘could help hospitals alone to the tune of 50 to 70 million per year'
